nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP1A2—Anagrelide—hematologic cancer	0.0355	0.0591	CbGbCtD
Mexiletine—CYP2B6—Thiotepa—hematologic cancer	0.0347	0.0579	CbGbCtD
Mexiletine—CYP2E1—Thalidomide—hematologic cancer	0.0227	0.0378	CbGbCtD
Mexiletine—CYP2B6—Ifosfamide—hematologic cancer	0.0197	0.0328	CbGbCtD
Mexiletine—CYP2E1—Dacarbazine—hematologic cancer	0.0195	0.0325	CbGbCtD
Mexiletine—CYP2D6—Lomustine—hematologic cancer	0.0188	0.0314	CbGbCtD
Mexiletine—CYP1A2—Carmustine—hematologic cancer	0.0186	0.031	CbGbCtD
Mexiletine—CYP2B6—Nilotinib—hematologic cancer	0.0171	0.0285	CbGbCtD
Mexiletine—CYP2D6—Idarubicin—hematologic cancer	0.0168	0.028	CbGbCtD
Mexiletine—CYP1A2—Methoxsalen—hematologic cancer	0.0158	0.0264	CbGbCtD
Mexiletine—CYP2E1—Mitoxantrone—hematologic cancer	0.0151	0.0252	CbGbCtD
Mexiletine—CYP1A2—Bortezomib—hematologic cancer	0.0151	0.0251	CbGbCtD
Mexiletine—CYP1A2—Daunorubicin—hematologic cancer	0.0144	0.024	CbGbCtD
Mexiletine—CYP2D6—Hydroxyurea—hematologic cancer	0.0143	0.0238	CbGbCtD
Mexiletine—CYP1A2—Alitretinoin—hematologic cancer	0.0141	0.0235	CbGbCtD
Mexiletine—CYP1A2—Thalidomide—hematologic cancer	0.0131	0.0219	CbGbCtD
Mexiletine—CYP3A4—Bexarotene—hematologic cancer	0.0129	0.0215	CbGbCtD
Mexiletine—CYP2D6—Bortezomib—hematologic cancer	0.0124	0.0207	CbGbCtD
Mexiletine—CYP3A4—Busulfan—hematologic cancer	0.012	0.0199	CbGbCtD
Mexiletine—CYP3A4—Lomustine—hematologic cancer	0.012	0.0199	CbGbCtD
Mexiletine—CYP2B6—Irinotecan—hematologic cancer	0.0118	0.0196	CbGbCtD
Mexiletine—CYP1A2—Dacarbazine—hematologic cancer	0.0113	0.0188	CbGbCtD
Mexiletine—CYP1A2—Imatinib—hematologic cancer	0.011	0.0184	CbGbCtD
Mexiletine—CYP3A4—Thiotepa—hematologic cancer	0.0107	0.0178	CbGbCtD
Mexiletine—CYP2B6—Cisplatin—hematologic cancer	0.00959	0.016	CbGbCtD
Mexiletine—CYP2E1—Etoposide—hematologic cancer	0.00955	0.0159	CbGbCtD
Mexiletine—CYP2D6—Imatinib—hematologic cancer	0.00909	0.0151	CbGbCtD
Mexiletine—CYP1A2—Dasatinib—hematologic cancer	0.00887	0.0148	CbGbCtD
Mexiletine—CYP3A4—Methoxsalen—hematologic cancer	0.0083	0.0138	CbGbCtD
Mexiletine—CYP2D6—Nilotinib—hematologic cancer	0.00826	0.0138	CbGbCtD
Mexiletine—CYP2D6—Vinorelbine—hematologic cancer	0.00819	0.0137	CbGbCtD
Mexiletine—CYP3A4—Bortezomib—hematologic cancer	0.00789	0.0131	CbGbCtD
Mexiletine—CYP2E1—Dexamethasone—hematologic cancer	0.00785	0.0131	CbGbCtD
Mexiletine—CYP2B6—Dexamethasone—hematologic cancer	0.00774	0.0129	CbGbCtD
Mexiletine—CYP3A4—Daunorubicin—hematologic cancer	0.00755	0.0126	CbGbCtD
Mexiletine—CYP3A4—Cytarabine—hematologic cancer	0.00666	0.0111	CbGbCtD
Mexiletine—CYP3A4—Teniposide—hematologic cancer	0.00656	0.0109	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—hematologic cancer	0.00642	0.0107	CbGbCtD
Mexiletine—CYP3A4—Ifosfamide—hematologic cancer	0.00605	0.0101	CbGbCtD
Mexiletine—CYP3A4—Imatinib—hematologic cancer	0.00578	0.00963	CbGbCtD
Mexiletine—CYP1A2—Etoposide—hematologic cancer	0.00552	0.0092	CbGbCtD
Mexiletine—CYP3A4—Ruxolitinib—hematologic cancer	0.00545	0.00907	CbGbCtD
Mexiletine—CYP3A4—Nilotinib—hematologic cancer	0.00526	0.00875	CbGbCtD
Mexiletine—CYP3A4—Vinorelbine—hematologic cancer	0.00521	0.00868	CbGbCtD
Mexiletine—CYP2D6—Vinblastine—hematologic cancer	0.00505	0.00841	CbGbCtD
Mexiletine—CYP3A4—Triamcinolone—hematologic cancer	0.00477	0.00794	CbGbCtD
Mexiletine—CYP3A4—Dasatinib—hematologic cancer	0.00464	0.00774	CbGbCtD
Mexiletine—CYP3A4—Mitoxantrone—hematologic cancer	0.00459	0.00764	CbGbCtD
Mexiletine—CYP3A4—Betamethasone—hematologic cancer	0.00409	0.00681	CbGbCtD
Mexiletine—CYP3A4—Prednisolone—hematologic cancer	0.00403	0.00672	CbGbCtD
Mexiletine—CYP3A4—Prednisone—hematologic cancer	0.00381	0.00635	CbGbCtD
Mexiletine—CYP2D6—Dexamethasone—hematologic cancer	0.00374	0.00623	CbGbCtD
Mexiletine—CYP3A4—Irinotecan—hematologic cancer	0.00361	0.00602	CbGbCtD
Mexiletine—CYP3A4—Vinblastine—hematologic cancer	0.00321	0.00535	CbGbCtD
Mexiletine—CYP3A4—Vincristine—hematologic cancer	0.00316	0.00526	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—hematologic cancer	0.0031	0.00517	CbGbCtD
Mexiletine—CYP3A4—Etoposide—hematologic cancer	0.00289	0.00482	CbGbCtD
Mexiletine—CYP3A4—Dexamethasone—hematologic cancer	0.00238	0.00396	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—hematologic cancer	0.00197	0.00329	CbGbCtD
Mexiletine—SCN2A—hematopoietic system—hematologic cancer	0.00183	0.063	CbGeAlD
Mexiletine—SCN10A—hematopoietic system—hematologic cancer	0.00176	0.0607	CbGeAlD
Mexiletine—AHR—blood—hematologic cancer	0.00149	0.0515	CbGeAlD
Mexiletine—AHR—bone marrow—hematologic cancer	0.00145	0.0499	CbGeAlD
Mexiletine—SCN9A—lung—hematologic cancer	0.00134	0.0463	CbGeAlD
Mexiletine—AHR—lung—hematologic cancer	0.00131	0.0452	CbGeAlD
Mexiletine—SCN9A—testis—hematologic cancer	0.00127	0.0437	CbGeAlD
Mexiletine—AHR—testis—hematologic cancer	0.00124	0.0426	CbGeAlD
Mexiletine—SCN2A—blood—hematologic cancer	0.00121	0.0417	CbGeAlD
Mexiletine—SCN10A—blood—hematologic cancer	0.00117	0.0402	CbGeAlD
Mexiletine—SCN4A—testis—hematologic cancer	0.00113	0.039	CbGeAlD
Mexiletine—SCN5A—blood—hematologic cancer	0.00106	0.0366	CbGeAlD
Mexiletine—SCN10A—lung—hematologic cancer	0.00102	0.0353	CbGeAlD
Mexiletine—SCN9A—lymph node—hematologic cancer	0.000918	0.0317	CbGeAlD
Mexiletine—AHR—lymph node—hematologic cancer	0.000896	0.0309	CbGeAlD
Mexiletine—CYP1A2—hematopoietic system—hematologic cancer	0.000842	0.029	CbGeAlD
Mexiletine—CYP2B6—hematopoietic system—hematologic cancer	0.000807	0.0278	CbGeAlD
Mexiletine—CYP2E1—hematopoietic system—hematologic cancer	0.000758	0.0261	CbGeAlD
Mexiletine—SCN10A—lymph node—hematologic cancer	0.000699	0.0241	CbGeAlD
Mexiletine—CYP2B6—gonad—hematologic cancer	0.000614	0.0212	CbGeAlD
Mexiletine—CYP3A4—hematopoietic system—hematologic cancer	0.00061	0.021	CbGeAlD
Mexiletine—CYP2D6—hematopoietic system—hematologic cancer	0.0006	0.0207	CbGeAlD
Mexiletine—CYP1A2—blood—hematologic cancer	0.000558	0.0192	CbGeAlD
Mexiletine—CYP2B6—blood—hematologic cancer	0.000535	0.0184	CbGeAlD
Mexiletine—CYP2E1—blood—hematologic cancer	0.000502	0.0173	CbGeAlD
Mexiletine—CYP1A2—lung—hematologic cancer	0.000489	0.0169	CbGeAlD
Mexiletine—CYP2B6—lung—hematologic cancer	0.000469	0.0162	CbGeAlD
Mexiletine—CYP2B6—testis—hematologic cancer	0.000442	0.0153	CbGeAlD
Mexiletine—CYP2E1—lung—hematologic cancer	0.00044	0.0152	CbGeAlD
Mexiletine—CYP2E1—testis—hematologic cancer	0.000415	0.0143	CbGeAlD
Mexiletine—CYP3A4—blood—hematologic cancer	0.000404	0.0139	CbGeAlD
Mexiletine—CYP2D6—blood—hematologic cancer	0.000397	0.0137	CbGeAlD
Mexiletine—CYP2D6—testis—hematologic cancer	0.000329	0.0113	CbGeAlD
Mexiletine—Pain—Triamcinolone—hematologic cancer	4.5e-05	0.000166	CcSEcCtD
Mexiletine—Headache—Vincristine—hematologic cancer	4.49e-05	0.000166	CcSEcCtD
Mexiletine—Loss of consciousness—Prednisone—hematologic cancer	4.48e-05	0.000165	CcSEcCtD
Mexiletine—Hypotension—Dexamethasone—hematologic cancer	4.46e-05	0.000165	CcSEcCtD
Mexiletine—Hypotension—Betamethasone—hematologic cancer	4.46e-05	0.000165	CcSEcCtD
Mexiletine—Nausea—Carmustine—hematologic cancer	4.46e-05	0.000164	CcSEcCtD
Mexiletine—Vomiting—Irinotecan—hematologic cancer	4.43e-05	0.000164	CcSEcCtD
Mexiletine—Vomiting—Mitoxantrone—hematologic cancer	4.43e-05	0.000164	CcSEcCtD
Mexiletine—Nausea—Alitretinoin—hematologic cancer	4.41e-05	0.000163	CcSEcCtD
Mexiletine—Convulsion—Prednisone—hematologic cancer	4.41e-05	0.000163	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—hematologic cancer	4.41e-05	0.000163	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—hematologic cancer	4.4e-05	0.000162	CcSEcCtD
Mexiletine—Hypertension—Prednisone—hematologic cancer	4.4e-05	0.000162	CcSEcCtD
Mexiletine—Rash—Mitoxantrone—hematologic cancer	4.4e-05	0.000162	CcSEcCtD
Mexiletine—Rash—Irinotecan—hematologic cancer	4.4e-05	0.000162	CcSEcCtD
Mexiletine—Dermatitis—Mitoxantrone—hematologic cancer	4.39e-05	0.000162	CcSEcCtD
Mexiletine—Dermatitis—Irinotecan—hematologic cancer	4.39e-05	0.000162	CcSEcCtD
Mexiletine—Headache—Mitoxantrone—hematologic cancer	4.37e-05	0.000161	CcSEcCtD
Mexiletine—Headache—Irinotecan—hematologic cancer	4.37e-05	0.000161	CcSEcCtD
Mexiletine—Nausea—Ifosfamide—hematologic cancer	4.36e-05	0.000161	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.35e-05	0.00016	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.35e-05	0.00016	CcSEcCtD
Mexiletine—Arthralgia—Prednisone—hematologic cancer	4.34e-05	0.00016	CcSEcCtD
Mexiletine—Feeling abnormal—Triamcinolone—hematologic cancer	4.34e-05	0.00016	CcSEcCtD
Mexiletine—Diarrhoea—Cisplatin—hematologic cancer	4.33e-05	0.00016	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—hematologic cancer	4.33e-05	0.00016	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—hematologic cancer	4.32e-05	0.000159	CcSEcCtD
Mexiletine—Vomiting—Gemcitabine—hematologic cancer	4.32e-05	0.000159	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—hematologic cancer	4.31e-05	0.000159	CcSEcCtD
Mexiletine—Paraesthesia—Dexamethasone—hematologic cancer	4.29e-05	0.000158	CcSEcCtD
Mexiletine—Paraesthesia—Betamethasone—hematologic cancer	4.29e-05	0.000158	CcSEcCtD
Mexiletine—Discomfort—Prednisone—hematologic cancer	4.28e-05	0.000158	CcSEcCtD
Mexiletine—Rash—Gemcitabine—hematologic cancer	4.28e-05	0.000158	CcSEcCtD
Mexiletine—Dermatitis—Gemcitabine—hematologic cancer	4.28e-05	0.000158	CcSEcCtD
Mexiletine—Hypersensitivity—Etoposide—hematologic cancer	4.27e-05	0.000158	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—hematologic cancer	4.27e-05	0.000157	CcSEcCtD
Mexiletine—Headache—Gemcitabine—hematologic cancer	4.26e-05	0.000157	CcSEcCtD
Mexiletine—Nausea—Vincristine—hematologic cancer	4.25e-05	0.000157	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—hematologic cancer	4.23e-05	0.000156	CcSEcCtD
Mexiletine—Hypersensitivity—Prednisolone—hematologic cancer	4.22e-05	0.000156	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—hematologic cancer	4.21e-05	0.000155	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—hematologic cancer	4.2e-05	0.000155	CcSEcCtD
Mexiletine—Dyspepsia—Betamethasone—hematologic cancer	4.2e-05	0.000155	CcSEcCtD
Mexiletine—Dyspepsia—Dexamethasone—hematologic cancer	4.2e-05	0.000155	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—hematologic cancer	4.17e-05	0.000154	CcSEcCtD
Mexiletine—Asthenia—Etoposide—hematologic cancer	4.16e-05	0.000154	CcSEcCtD
Mexiletine—Body temperature increased—Triamcinolone—hematologic cancer	4.16e-05	0.000153	CcSEcCtD
Mexiletine—Oedema—Prednisone—hematologic cancer	4.16e-05	0.000153	CcSEcCtD
Mexiletine—Nausea—Mitoxantrone—hematologic cancer	4.14e-05	0.000153	CcSEcCtD
Mexiletine—Nausea—Irinotecan—hematologic cancer	4.14e-05	0.000153	CcSEcCtD
Mexiletine—Fatigue—Betamethasone—hematologic cancer	4.12e-05	0.000152	CcSEcCtD
Mexiletine—Fatigue—Dexamethasone—hematologic cancer	4.12e-05	0.000152	CcSEcCtD
Mexiletine—Shock—Prednisone—hematologic cancer	4.09e-05	0.000151	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—hematologic cancer	4.09e-05	0.000151	CcSEcCtD
Mexiletine—Pain—Dexamethasone—hematologic cancer	4.08e-05	0.000151	CcSEcCtD
Mexiletine—Pain—Betamethasone—hematologic cancer	4.08e-05	0.000151	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—hematologic cancer	4.08e-05	0.000151	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—hematologic cancer	4.04e-05	0.000149	CcSEcCtD
Mexiletine—Nausea—Gemcitabine—hematologic cancer	4.04e-05	0.000149	CcSEcCtD
Mexiletine—Vomiting—Cisplatin—hematologic cancer	4.03e-05	0.000149	CcSEcCtD
Mexiletine—Hyperhidrosis—Prednisone—hematologic cancer	4.02e-05	0.000148	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—hematologic cancer	4.01e-05	0.000148	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—hematologic cancer	4e-05	0.000148	CcSEcCtD
Mexiletine—Rash—Cisplatin—hematologic cancer	3.99e-05	0.000147	CcSEcCtD
Mexiletine—Dermatitis—Cisplatin—hematologic cancer	3.99e-05	0.000147	CcSEcCtD
Mexiletine—Diarrhoea—Etoposide—hematologic cancer	3.97e-05	0.000146	CcSEcCtD
Mexiletine—Ill-defined disorder—Methotrexate—hematologic cancer	3.95e-05	0.000146	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—hematologic cancer	3.95e-05	0.000146	CcSEcCtD
Mexiletine—Feeling abnormal—Dexamethasone—hematologic cancer	3.93e-05	0.000145	CcSEcCtD
Mexiletine—Feeling abnormal—Betamethasone—hematologic cancer	3.93e-05	0.000145	CcSEcCtD
Mexiletine—Tension—Epirubicin—hematologic cancer	3.91e-05	0.000144	CcSEcCtD
Mexiletine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.9e-05	0.000144	CcSEcCtD
Mexiletine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.9e-05	0.000144	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—hematologic cancer	3.9e-05	0.000144	CcSEcCtD
Mexiletine—Hypersensitivity—Triamcinolone—hematologic cancer	3.88e-05	0.000143	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—hematologic cancer	3.87e-05	0.000143	CcSEcCtD
Mexiletine—Malaise—Methotrexate—hematologic cancer	3.84e-05	0.000142	CcSEcCtD
Mexiletine—Dizziness—Etoposide—hematologic cancer	3.84e-05	0.000142	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—hematologic cancer	3.83e-05	0.000141	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—hematologic cancer	3.81e-05	0.000141	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.79e-05	0.00014	CcSEcCtD
Mexiletine—Dizziness—Prednisolone—hematologic cancer	3.78e-05	0.00014	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—hematologic cancer	3.78e-05	0.00014	CcSEcCtD
Mexiletine—Asthenia—Triamcinolone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Mexiletine—Abdominal pain—Betamethasone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Mexiletine—Body temperature increased—Dexamethasone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Mexiletine—Body temperature increased—Betamethasone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Mexiletine—Abdominal pain—Dexamethasone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Mexiletine—Nausea—Cisplatin—hematologic cancer	3.76e-05	0.000139	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—hematologic cancer	3.75e-05	0.000139	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—hematologic cancer	3.74e-05	0.000138	CcSEcCtD
Mexiletine—Paraesthesia—Prednisone—hematologic cancer	3.73e-05	0.000138	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—hematologic cancer	3.7e-05	0.000136	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—hematologic cancer	3.69e-05	0.000136	CcSEcCtD
Mexiletine—Vomiting—Etoposide—hematologic cancer	3.69e-05	0.000136	CcSEcCtD
Mexiletine—Dyspepsia—Prednisone—hematologic cancer	3.66e-05	0.000135	CcSEcCtD
Mexiletine—Rash—Etoposide—hematologic cancer	3.66e-05	0.000135	CcSEcCtD
Mexiletine—Dermatitis—Etoposide—hematologic cancer	3.65e-05	0.000135	CcSEcCtD
Mexiletine—Headache—Etoposide—hematologic cancer	3.63e-05	0.000134	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—hematologic cancer	3.62e-05	0.000134	CcSEcCtD
Mexiletine—Chest pain—Methotrexate—hematologic cancer	3.62e-05	0.000134	CcSEcCtD
Mexiletine—Tension—Doxorubicin—hematologic cancer	3.62e-05	0.000133	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—hematologic cancer	3.61e-05	0.000133	CcSEcCtD
Mexiletine—Rash—Prednisolone—hematologic cancer	3.61e-05	0.000133	CcSEcCtD
Mexiletine—Dermatitis—Prednisolone—hematologic cancer	3.6e-05	0.000133	CcSEcCtD
Mexiletine—Malaise—Epirubicin—hematologic cancer	3.59e-05	0.000133	CcSEcCtD
Mexiletine—Fatigue—Prednisone—hematologic cancer	3.58e-05	0.000132	CcSEcCtD
Mexiletine—Headache—Prednisolone—hematologic cancer	3.58e-05	0.000132	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—hematologic cancer	3.58e-05	0.000132	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—hematologic cancer	3.58e-05	0.000132	CcSEcCtD
Mexiletine—Syncope—Epirubicin—hematologic cancer	3.57e-05	0.000132	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—hematologic cancer	3.57e-05	0.000132	CcSEcCtD
Mexiletine—Constipation—Prednisone—hematologic cancer	3.56e-05	0.000131	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—hematologic cancer	3.54e-05	0.000131	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—hematologic cancer	3.52e-05	0.00013	CcSEcCtD
Mexiletine—Confusional state—Methotrexate—hematologic cancer	3.5e-05	0.000129	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—hematologic cancer	3.5e-05	0.000129	CcSEcCtD
Mexiletine—Dizziness—Triamcinolone—hematologic cancer	3.48e-05	0.000128	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—hematologic cancer	3.47e-05	0.000128	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—hematologic cancer	3.45e-05	0.000127	CcSEcCtD
Mexiletine—Nausea—Etoposide—hematologic cancer	3.45e-05	0.000127	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—hematologic cancer	3.44e-05	0.000127	CcSEcCtD
Mexiletine—Feeling abnormal—Prednisone—hematologic cancer	3.43e-05	0.000126	CcSEcCtD
Mexiletine—Asthenia—Dexamethasone—hematologic cancer	3.43e-05	0.000126	CcSEcCtD
Mexiletine—Asthenia—Betamethasone—hematologic cancer	3.43e-05	0.000126	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—hematologic cancer	3.42e-05	0.000126	CcSEcCtD
Mexiletine—Thrombocytopenia—Methotrexate—hematologic cancer	3.4e-05	0.000126	CcSEcCtD
Mexiletine—Gastrointestinal pain—Prednisone—hematologic cancer	3.4e-05	0.000125	CcSEcCtD
Mexiletine—Nausea—Prednisolone—hematologic cancer	3.4e-05	0.000125	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—hematologic cancer	3.39e-05	0.000125	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—hematologic cancer	3.39e-05	0.000125	CcSEcCtD
Mexiletine—Hyperhidrosis—Methotrexate—hematologic cancer	3.36e-05	0.000124	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—hematologic cancer	3.35e-05	0.000124	CcSEcCtD
Mexiletine—Vomiting—Triamcinolone—hematologic cancer	3.35e-05	0.000123	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—hematologic cancer	3.32e-05	0.000123	CcSEcCtD
Mexiletine—Rash—Triamcinolone—hematologic cancer	3.32e-05	0.000122	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—hematologic cancer	3.32e-05	0.000122	CcSEcCtD
Mexiletine—Dermatitis—Triamcinolone—hematologic cancer	3.31e-05	0.000122	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—hematologic cancer	3.31e-05	0.000122	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—hematologic cancer	3.3e-05	0.000122	CcSEcCtD
Mexiletine—Headache—Triamcinolone—hematologic cancer	3.3e-05	0.000122	CcSEcCtD
Mexiletine—Abdominal pain—Prednisone—hematologic cancer	3.29e-05	0.000121	CcSEcCtD
Mexiletine—Body temperature increased—Prednisone—hematologic cancer	3.29e-05	0.000121	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—hematologic cancer	3.28e-05	0.000121	CcSEcCtD
Mexiletine—Diarrhoea—Betamethasone—hematologic cancer	3.27e-05	0.000121	CcSEcCtD
Mexiletine—Diarrhoea—Dexamethasone—hematologic cancer	3.27e-05	0.000121	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—hematologic cancer	3.26e-05	0.00012	CcSEcCtD
Mexiletine—Oedema—Epirubicin—hematologic cancer	3.25e-05	0.00012	CcSEcCtD
Mexiletine—Hypotension—Methotrexate—hematologic cancer	3.25e-05	0.00012	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—hematologic cancer	3.24e-05	0.00012	CcSEcCtD
Mexiletine—Shock—Epirubicin—hematologic cancer	3.2e-05	0.000118	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—hematologic cancer	3.19e-05	0.000118	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—hematologic cancer	3.18e-05	0.000117	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—hematologic cancer	3.18e-05	0.000117	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.17e-05	0.000117	CcSEcCtD
Mexiletine—Dizziness—Betamethasone—hematologic cancer	3.16e-05	0.000116	CcSEcCtD
Mexiletine—Dizziness—Dexamethasone—hematologic cancer	3.16e-05	0.000116	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—hematologic cancer	3.14e-05	0.000116	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—hematologic cancer	3.14e-05	0.000116	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—hematologic cancer	3.14e-05	0.000116	CcSEcCtD
Mexiletine—Nausea—Triamcinolone—hematologic cancer	3.13e-05	0.000115	CcSEcCtD
Mexiletine—Paraesthesia—Methotrexate—hematologic cancer	3.12e-05	0.000115	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—hematologic cancer	3.1e-05	0.000114	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—hematologic cancer	3.1e-05	0.000114	CcSEcCtD
Mexiletine—Somnolence—Methotrexate—hematologic cancer	3.09e-05	0.000114	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—hematologic cancer	3.07e-05	0.000113	CcSEcCtD
Mexiletine—Hypersensitivity—Prednisone—hematologic cancer	3.06e-05	0.000113	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—hematologic cancer	3.06e-05	0.000113	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—hematologic cancer	3.04e-05	0.000112	CcSEcCtD
Mexiletine—Vomiting—Betamethasone—hematologic cancer	3.04e-05	0.000112	CcSEcCtD
Mexiletine—Vomiting—Dexamethasone—hematologic cancer	3.04e-05	0.000112	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—hematologic cancer	3.03e-05	0.000112	CcSEcCtD
Mexiletine—Rash—Dexamethasone—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Mexiletine—Rash—Betamethasone—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Mexiletine—Dermatitis—Dexamethasone—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Mexiletine—Dermatitis—Betamethasone—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Mexiletine—Fatigue—Methotrexate—hematologic cancer	3e-05	0.000111	CcSEcCtD
Mexiletine—Headache—Dexamethasone—hematologic cancer	2.99e-05	0.00011	CcSEcCtD
Mexiletine—Headache—Betamethasone—hematologic cancer	2.99e-05	0.00011	CcSEcCtD
Mexiletine—Asthenia—Prednisone—hematologic cancer	2.98e-05	0.00011	CcSEcCtD
Mexiletine—Pain—Methotrexate—hematologic cancer	2.97e-05	0.00011	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.96e-05	0.000109	CcSEcCtD
Mexiletine—Shock—Doxorubicin—hematologic cancer	2.96e-05	0.000109	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.95e-05	0.000109	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—hematologic cancer	2.92e-05	0.000108	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.91e-05	0.000107	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—hematologic cancer	2.9e-05	0.000107	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—hematologic cancer	2.89e-05	0.000107	CcSEcCtD
Mexiletine—Feeling abnormal—Methotrexate—hematologic cancer	2.86e-05	0.000106	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—hematologic cancer	2.86e-05	0.000106	CcSEcCtD
Mexiletine—Diarrhoea—Prednisone—hematologic cancer	2.84e-05	0.000105	CcSEcCtD
Mexiletine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.84e-05	0.000105	CcSEcCtD
Mexiletine—Nausea—Betamethasone—hematologic cancer	2.84e-05	0.000105	CcSEcCtD
Mexiletine—Nausea—Dexamethasone—hematologic cancer	2.84e-05	0.000105	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—hematologic cancer	2.81e-05	0.000104	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—hematologic cancer	2.8e-05	0.000103	CcSEcCtD
Mexiletine—Pain—Epirubicin—hematologic cancer	2.78e-05	0.000103	CcSEcCtD
Mexiletine—Constipation—Epirubicin—hematologic cancer	2.78e-05	0.000103	CcSEcCtD
Mexiletine—Dizziness—Prednisone—hematologic cancer	2.75e-05	0.000101	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—hematologic cancer	2.75e-05	0.000101	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—hematologic cancer	2.75e-05	0.000101	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.74e-05	0.000101	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—hematologic cancer	2.7e-05	9.97e-05	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—hematologic cancer	2.68e-05	9.9e-05	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—hematologic cancer	2.68e-05	9.89e-05	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—hematologic cancer	2.67e-05	9.87e-05	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.66e-05	9.81e-05	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—hematologic cancer	2.65e-05	9.77e-05	CcSEcCtD
Mexiletine—Vomiting—Prednisone—hematologic cancer	2.64e-05	9.75e-05	CcSEcCtD
Mexiletine—Rash—Prednisone—hematologic cancer	2.62e-05	9.67e-05	CcSEcCtD
Mexiletine—Dermatitis—Prednisone—hematologic cancer	2.62e-05	9.66e-05	CcSEcCtD
Mexiletine—Headache—Prednisone—hematologic cancer	2.6e-05	9.61e-05	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—hematologic cancer	2.59e-05	9.57e-05	CcSEcCtD
Mexiletine—Pain—Doxorubicin—hematologic cancer	2.57e-05	9.49e-05	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—hematologic cancer	2.57e-05	9.49e-05	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—hematologic cancer	2.57e-05	9.48e-05	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—hematologic cancer	2.57e-05	9.48e-05	CcSEcCtD
Mexiletine—Hypersensitivity—Methotrexate—hematologic cancer	2.56e-05	9.45e-05	CcSEcCtD
Mexiletine—Asthenia—Methotrexate—hematologic cancer	2.49e-05	9.2e-05	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—hematologic cancer	2.48e-05	9.15e-05	CcSEcCtD
Mexiletine—Nausea—Prednisone—hematologic cancer	2.47e-05	9.11e-05	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.46e-05	9.08e-05	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—hematologic cancer	2.4e-05	8.84e-05	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—hematologic cancer	2.38e-05	8.78e-05	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—hematologic cancer	2.38e-05	8.78e-05	CcSEcCtD
Mexiletine—Diarrhoea—Methotrexate—hematologic cancer	2.38e-05	8.77e-05	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—hematologic cancer	2.33e-05	8.61e-05	CcSEcCtD
Mexiletine—Dizziness—Methotrexate—hematologic cancer	2.3e-05	8.48e-05	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—hematologic cancer	2.22e-05	8.21e-05	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—hematologic cancer	2.22e-05	8.18e-05	CcSEcCtD
Mexiletine—Vomiting—Methotrexate—hematologic cancer	2.21e-05	8.15e-05	CcSEcCtD
Mexiletine—Rash—Methotrexate—hematologic cancer	2.19e-05	8.08e-05	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—hematologic cancer	2.19e-05	8.08e-05	CcSEcCtD
Mexiletine—Headache—Methotrexate—hematologic cancer	2.18e-05	8.03e-05	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—hematologic cancer	2.16e-05	7.97e-05	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—hematologic cancer	2.15e-05	7.93e-05	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—hematologic cancer	2.07e-05	7.63e-05	CcSEcCtD
Mexiletine—Nausea—Methotrexate—hematologic cancer	2.06e-05	7.62e-05	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—hematologic cancer	2.06e-05	7.6e-05	CcSEcCtD
Mexiletine—Rash—Epirubicin—hematologic cancer	2.05e-05	7.57e-05	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—hematologic cancer	2.05e-05	7.56e-05	CcSEcCtD
Mexiletine—Headache—Epirubicin—hematologic cancer	2.04e-05	7.52e-05	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—hematologic cancer	1.99e-05	7.34e-05	CcSEcCtD
Mexiletine—Nausea—Epirubicin—hematologic cancer	1.93e-05	7.13e-05	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—hematologic cancer	1.91e-05	7.06e-05	CcSEcCtD
Mexiletine—Rash—Doxorubicin—hematologic cancer	1.9e-05	7e-05	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—hematologic cancer	1.9e-05	6.99e-05	CcSEcCtD
Mexiletine—Headache—Doxorubicin—hematologic cancer	1.88e-05	6.95e-05	CcSEcCtD
Mexiletine—Nausea—Doxorubicin—hematologic cancer	1.79e-05	6.59e-05	CcSEcCtD
Mexiletine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.18e-05	0.000118	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GBA—hematologic cancer	1.18e-05	0.000118	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CA9—hematologic cancer	1.18e-05	0.000118	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ACP5—hematologic cancer	1.18e-05	0.000118	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HDC—hematologic cancer	1.18e-05	0.000118	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NCOR2—hematologic cancer	1.16e-05	0.000117	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TNF—hematologic cancer	1.16e-05	0.000116	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CA9—hematologic cancer	1.15e-05	0.000116	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ACP5—hematologic cancer	1.15e-05	0.000116	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—hematologic cancer	1.15e-05	0.000115	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NCOR2—hematologic cancer	1.14e-05	0.000114	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—IDH1—hematologic cancer	1.11e-05	0.000111	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.1e-05	0.00011	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.1e-05	0.00011	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TXN—hematologic cancer	1.1e-05	0.00011	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ABCC3—hematologic cancer	1.1e-05	0.00011	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTO1—hematologic cancer	1.1e-05	0.00011	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—IDH1—hematologic cancer	1.08e-05	0.000109	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.08e-05	0.000108	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CDA—hematologic cancer	1.08e-05	0.000108	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTO1—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TXN—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ABCC3—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SPHK1—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SPHK1—hematologic cancer	1.05e-05	0.000105	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PC—hematologic cancer	1.04e-05	0.000104	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—UGT1A1—hematologic cancer	1.03e-05	0.000103	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—UGT1A1—hematologic cancer	1.01e-05	0.000101	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SLC22A1—hematologic cancer	1e-05	0.0001	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CRABP1—hematologic cancer	1e-05	0.0001	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GBA—hematologic cancer	1e-05	0.0001	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1e-05	0.0001	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SLC22A1—hematologic cancer	9.81e-06	9.84e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CRABP1—hematologic cancer	9.81e-06	9.84e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALOX5—hematologic cancer	9.76e-06	9.79e-05	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—hematologic cancer	9.74e-06	9.77e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—FHL2—hematologic cancer	9.63e-06	9.66e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—DCK—hematologic cancer	9.58e-06	9.61e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.58e-06	9.61e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ASNS—hematologic cancer	9.58e-06	9.61e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALOX5—hematologic cancer	9.56e-06	9.59e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NUP98—hematologic cancer	9.45e-06	9.48e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AGRN—hematologic cancer	9.44e-06	9.47e-05	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—IL6—hematologic cancer	9.32e-06	9.35e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NUP98—hematologic cancer	9.26e-06	9.29e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ADCY7—hematologic cancer	9.18e-06	9.21e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NCOA3—hematologic cancer	9.18e-06	9.21e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTAP—hematologic cancer	9.15e-06	9.18e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NUP214—hematologic cancer	9.11e-06	9.14e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HDC—hematologic cancer	9.08e-06	9.11e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ADCY7—hematologic cancer	8.99e-06	9.02e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NCOA3—hematologic cancer	8.99e-06	9.02e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HMMR—hematologic cancer	8.95e-06	8.98e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—IDH2—hematologic cancer	8.95e-06	8.98e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ABCG2—hematologic cancer	8.93e-06	8.96e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—MTR—hematologic cancer	8.93e-06	8.96e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NUP214—hematologic cancer	8.93e-06	8.95e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ENO2—hematologic cancer	8.76e-06	8.78e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ABCG2—hematologic cancer	8.75e-06	8.77e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—MTR—hematologic cancer	8.75e-06	8.77e-05	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—AKT1—hematologic cancer	8.6e-06	8.63e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ENO2—hematologic cancer	8.58e-06	8.6e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTT1—hematologic cancer	8.49e-06	8.52e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ARNTL—hematologic cancer	8.42e-06	8.44e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTT1—hematologic cancer	8.32e-06	8.34e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CDA—hematologic cancer	8.31e-06	8.33e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SDC1—hematologic cancer	8.3e-06	8.33e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CA9—hematologic cancer	8.19e-06	8.21e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ACP5—hematologic cancer	8.19e-06	8.21e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—FHL2—hematologic cancer	8.16e-06	8.18e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SDC1—hematologic cancer	8.13e-06	8.16e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOR2—hematologic cancer	8.08e-06	8.11e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AGRN—hematologic cancer	8e-06	8.03e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PC—hematologic cancer	8e-06	8.02e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GBA—hematologic cancer	7.72e-06	7.75e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.72e-06	7.75e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—IDH1—hematologic cancer	7.7e-06	7.72e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCC3—hematologic cancer	7.61e-06	7.64e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TXN—hematologic cancer	7.61e-06	7.64e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTO1—hematologic cancer	7.61e-06	7.64e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HMMR—hematologic cancer	7.58e-06	7.61e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—IDH2—hematologic cancer	7.58e-06	7.61e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SPHK1—hematologic cancer	7.45e-06	7.47e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	7.16e-06	7.18e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.15e-06	7.17e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ARNTL—hematologic cancer	7.13e-06	7.15e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTAP—hematologic cancer	7.06e-06	7.09e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CD44—hematologic cancer	7.06e-06	7.08e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NQO1—hematologic cancer	7.06e-06	7.08e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	6.96e-06	6.98e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CRABP1—hematologic cancer	6.96e-06	6.98e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CA9—hematologic cancer	6.94e-06	6.96e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ACP5—hematologic cancer	6.94e-06	6.96e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CD44—hematologic cancer	6.91e-06	6.93e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NQO1—hematologic cancer	6.91e-06	6.93e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.85e-06	6.87e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALOX5—hematologic cancer	6.79e-06	6.81e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYCS—hematologic cancer	6.68e-06	6.7e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	6.64e-06	6.66e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NUP98—hematologic cancer	6.57e-06	6.59e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYCS—hematologic cancer	6.54e-06	6.56e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—IDH1—hematologic cancer	6.52e-06	6.54e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	6.5e-06	6.52e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TXN—hematologic cancer	6.45e-06	6.47e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.45e-06	6.47e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.45e-06	6.47e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.38e-06	6.4e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.38e-06	6.4e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NUP214—hematologic cancer	6.33e-06	6.35e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.31e-06	6.33e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—FHL2—hematologic cancer	6.3e-06	6.32e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTR—hematologic cancer	6.21e-06	6.22e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.21e-06	6.22e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AGRN—hematologic cancer	6.17e-06	6.19e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.09e-06	6.1e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.06e-06	6.08e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.9e-06	5.92e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.9e-06	5.92e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.9e-06	5.92e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTP1—hematologic cancer	5.89e-06	5.9e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HMMR—hematologic cancer	5.85e-06	5.87e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—IDH2—hematologic cancer	5.85e-06	5.87e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SDC1—hematologic cancer	5.77e-06	5.79e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTP1—hematologic cancer	5.77e-06	5.78e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.75e-06	5.77e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ABCB1—hematologic cancer	5.57e-06	5.59e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NUP98—hematologic cancer	5.57e-06	5.58e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.5e-06	5.52e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ABCB1—hematologic cancer	5.46e-06	5.47e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NCOR1—hematologic cancer	5.41e-06	5.43e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTM1—hematologic cancer	5.41e-06	5.43e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.4e-06	5.42e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.4e-06	5.42e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NUP214—hematologic cancer	5.37e-06	5.38e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CA9—hematologic cancer	5.35e-06	5.37e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ACP5—hematologic cancer	5.35e-06	5.37e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.31e-06	5.33e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTM1—hematologic cancer	5.3e-06	5.31e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NCOR1—hematologic cancer	5.3e-06	5.31e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.28e-06	5.3e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.26e-06	5.27e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTR—hematologic cancer	5.26e-06	5.27e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ENO2—hematologic cancer	5.16e-06	5.17e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.03e-06	5.05e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTT1—hematologic cancer	5e-06	5.02e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.98e-06	4.99e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TXN—hematologic cancer	4.98e-06	4.99e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.98e-06	4.99e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.92e-06	4.94e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CD44—hematologic cancer	4.91e-06	4.92e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NQO1—hematologic cancer	4.91e-06	4.92e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SDC1—hematologic cancer	4.89e-06	4.9e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.87e-06	4.89e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—MTHFR—hematologic cancer	4.78e-06	4.8e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—MTHFR—hematologic cancer	4.68e-06	4.7e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.68e-06	4.69e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.67e-06	4.68e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYCS—hematologic cancer	4.64e-06	4.66e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.61e-06	4.63e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.61e-06	4.62e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.55e-06	4.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.55e-06	4.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.44e-06	4.45e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.41e-06	4.42e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.3e-06	4.31e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.17e-06	4.18e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.17e-06	4.18e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NQO1—hematologic cancer	4.16e-06	4.17e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CD44—hematologic cancer	4.16e-06	4.17e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.14e-06	4.15e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.09e-06	4.1e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.07e-06	4.08e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTR—hematologic cancer	4.06e-06	4.07e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.06e-06	4.07e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	4.02e-06	4.03e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.98e-06	3.99e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.93e-06	3.95e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYCS—hematologic cancer	3.93e-06	3.94e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.91e-06	3.92e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.87e-06	3.88e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.86e-06	3.87e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.77e-06	3.78e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.76e-06	3.77e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.76e-06	3.77e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CREBBP—hematologic cancer	3.72e-06	3.74e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.65e-06	3.66e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	3.53e-06	3.54e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.52e-06	3.53e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALB—hematologic cancer	3.49e-06	3.5e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.47e-06	3.48e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.46e-06	3.47e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALB—hematologic cancer	3.41e-06	3.42e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.35e-06	3.36e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.33e-06	3.34e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.32e-06	3.33e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.28e-06	3.29e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.27e-06	3.28e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CD44—hematologic cancer	3.21e-06	3.22e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.21e-06	3.22e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.19e-06	3.19e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.19e-06	3.19e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	3.08e-06	3.09e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.03e-06	3.04e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.02e-06	3.02e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.01e-06	3.02e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.81e-06	2.82e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.79e-06	2.8e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.67e-06	2.68e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTEN—hematologic cancer	2.66e-06	2.67e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTEN—hematologic cancer	2.6e-06	2.61e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.59e-06	2.6e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—EP300—hematologic cancer	2.54e-06	2.54e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.53e-06	2.54e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—EP300—hematologic cancer	2.48e-06	2.49e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.48e-06	2.49e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.46e-06	2.47e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.46e-06	2.47e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.45e-06	2.46e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALB—hematologic cancer	2.42e-06	2.43e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.37e-06	2.37e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.32e-06	2.32e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.19e-06	2.2e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.17e-06	2.18e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.14e-06	2.15e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.08e-06	2.09e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALB—hematologic cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.96e-06	1.97e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.88e-06	1.88e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.85e-06	1.85e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.84e-06	1.84e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.83e-06	1.83e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—EP300—hematologic cancer	1.76e-06	1.77e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALB—hematologic cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.57e-06	1.57e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.52e-06	1.52e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—EP300—hematologic cancer	1.49e-06	1.5e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.4e-06	1.4e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.21e-06	1.21e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—EP300—hematologic cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.1e-06	1.11e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.07e-06	1.07e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—hematologic cancer	9.02e-07	9.05e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.53e-07	8.55e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—hematologic cancer	6.96e-07	6.99e-06	CbGpPWpGaD
